✦ LIBER ✦

PCN27 AN ANALYSIS OF COSTS ASSOCIATED WITH ADMINISTRATION OF TRASTUZUMAB-BASED COMBINATION IV THERAPIES IN METASTATIC BREAST CANCER PATIENTS IN A US POPULATION

✍ Scribed by GB Kruse; MM Amonkar; D Skonieczny; GL Smith

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P177 An analysis of non-drug costs assoc

✍ G. Kruse; M. Amonkar; D. Skonieczny; G. Smith 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

PCN28 COST-UTILITY ANALYSIS IN A SPANISH

✍ C Polanco; M Carulla; X Badia; A Ramirez-Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN97 TREATMENT OF PATIENTS WITH METASTA

✍ M Walker; J Unwin; C Relf; D Browning; M Amonkar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

A cost-effectiveness analysis of Hercept

✍ A. Ratcliffe; C. Poole; D. Miles 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A phase II trial of trastuzumab in combi

✍ Aruna Mani; Julie Roda; Donn Young; Michael A. Caligiuri; Gini F. Fleming; Peter 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 288 KB

A cost-benefit analysis of bevacizumab i

✍ Alberto J. Montero; Kiran Avancha; Stefan Glück; Gilberto Lopes 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 177 KB